Serum IL-33 level is associated with auto-antibodies but not with clinical response to biologic agents in rheumatoid arthritis

Rotation or Change of Biotherapy After First Anti-TNF Treatment Failure for Rheumatoid Arthritis (ROC), registered 22 October 2009, NCT01000441

Detalles Bibliográficos
Autores principales: Rivière, Elodie, Sellam, Jérémie, Pascaud, Juliette, Ravaud, Philippe, Gottenberg, Jacques-Eric, Mariette, Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994091/
https://www.ncbi.nlm.nih.gov/pubmed/29884223
http://dx.doi.org/10.1186/s13075-018-1628-6
_version_ 1783330355925745664
author Rivière, Elodie
Sellam, Jérémie
Pascaud, Juliette
Ravaud, Philippe
Gottenberg, Jacques-Eric
Mariette, Xavier
author_facet Rivière, Elodie
Sellam, Jérémie
Pascaud, Juliette
Ravaud, Philippe
Gottenberg, Jacques-Eric
Mariette, Xavier
author_sort Rivière, Elodie
collection PubMed
description Rotation or Change of Biotherapy After First Anti-TNF Treatment Failure for Rheumatoid Arthritis (ROC), registered 22 October 2009, NCT01000441
format Online
Article
Text
id pubmed-5994091
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-59940912018-06-21 Serum IL-33 level is associated with auto-antibodies but not with clinical response to biologic agents in rheumatoid arthritis Rivière, Elodie Sellam, Jérémie Pascaud, Juliette Ravaud, Philippe Gottenberg, Jacques-Eric Mariette, Xavier Arthritis Res Ther Letter Rotation or Change of Biotherapy After First Anti-TNF Treatment Failure for Rheumatoid Arthritis (ROC), registered 22 October 2009, NCT01000441 BioMed Central 2018-06-08 2018 /pmc/articles/PMC5994091/ /pubmed/29884223 http://dx.doi.org/10.1186/s13075-018-1628-6 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Letter
Rivière, Elodie
Sellam, Jérémie
Pascaud, Juliette
Ravaud, Philippe
Gottenberg, Jacques-Eric
Mariette, Xavier
Serum IL-33 level is associated with auto-antibodies but not with clinical response to biologic agents in rheumatoid arthritis
title Serum IL-33 level is associated with auto-antibodies but not with clinical response to biologic agents in rheumatoid arthritis
title_full Serum IL-33 level is associated with auto-antibodies but not with clinical response to biologic agents in rheumatoid arthritis
title_fullStr Serum IL-33 level is associated with auto-antibodies but not with clinical response to biologic agents in rheumatoid arthritis
title_full_unstemmed Serum IL-33 level is associated with auto-antibodies but not with clinical response to biologic agents in rheumatoid arthritis
title_short Serum IL-33 level is associated with auto-antibodies but not with clinical response to biologic agents in rheumatoid arthritis
title_sort serum il-33 level is associated with auto-antibodies but not with clinical response to biologic agents in rheumatoid arthritis
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994091/
https://www.ncbi.nlm.nih.gov/pubmed/29884223
http://dx.doi.org/10.1186/s13075-018-1628-6
work_keys_str_mv AT riviereelodie serumil33levelisassociatedwithautoantibodiesbutnotwithclinicalresponsetobiologicagentsinrheumatoidarthritis
AT sellamjeremie serumil33levelisassociatedwithautoantibodiesbutnotwithclinicalresponsetobiologicagentsinrheumatoidarthritis
AT pascaudjuliette serumil33levelisassociatedwithautoantibodiesbutnotwithclinicalresponsetobiologicagentsinrheumatoidarthritis
AT ravaudphilippe serumil33levelisassociatedwithautoantibodiesbutnotwithclinicalresponsetobiologicagentsinrheumatoidarthritis
AT gottenbergjacqueseric serumil33levelisassociatedwithautoantibodiesbutnotwithclinicalresponsetobiologicagentsinrheumatoidarthritis
AT mariettexavier serumil33levelisassociatedwithautoantibodiesbutnotwithclinicalresponsetobiologicagentsinrheumatoidarthritis

Ejemplares similares